Genome-wide association studies (GWAS), human postmortem brain studies, and magnetic resonance spectroscopy studies have identified similar gene expression changes in glutamatergic neurotransmission and glutamate receptor (GluR) expression among patients with schizophrenia, BD, and major depressive disorder (MDD) (29–32). The gene discussed is GSR; the disease is major depressive disorder.